- $4.49bn
- $6.01bn
- $1.24bn
- 66
- 81
- 77
- 87
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Total Revenue | 1,527 | 1,439 | 1,330 | 1,191 | 1,241 |
Losses, Benefits, and Adjustments | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 622 | 888 | 481 | 153 | 383 |
Operating Profit | 905 | 551 | 849 | 1,037 | 857 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 849 | 479 | 765 | 953 | 767 |
Provision for Income Taxes | |||||
Net Income After Taxes | 672 | 394 | 601 | 743 | 603 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 672 | 394 | 601 | 743 | 603 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 672 | 394 | 601 | 743 | 603 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.34 | 2.03 | 3.17 | 4.42 | 3.88 |
Dividends per Share |